REUTERS NEWS
From market-moving scoops and exclusive interviews to investigative reports and insightful commentary — this is Reuters Best.
From market-moving scoops and exclusive interviews to investigative reports and insightful commentary — this is Reuters Best.
Exclusives | Global
Merck, rivals eye deal for Inhibrx experimental cancer drug tied to Keytruda, sources say
Inhibrx Biosciences has drawn interest from drugmakers including Merck & Co, Germany’s Merck and Japan’s Ono Pharmaceutical for an experimental cancer treatment that could be valued at more than $8 billion, people familiar with the matter said.
22 April 2026, 9:51 am
Exclusives | South America
Peru pipeline rupture followed years of regulator warnings, documents show
22 April 2026, 9:43 am
Exclusives | Europe
Boots owners hire consultants for overhaul before possible 2027 London IPO, sources say
21 April 2026, 8:28 am
Exclusives | Middle East
Iran offers proposal allowing ships to exit Oman side of Hormuz free of attack, source says
16 April 2026, 10:50 am
